Late Consequences of Therapy of Acute Lymphoblastic Leukemia
Reference125 articles.
1. Farber, S., & Diamond, L. K. (1948). Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. The New England Journal of Medicine, 238(23), 787–793.
2. Ravindranath, Y. (1999). Forty-five-year follow-up of a childhood leukemia survivor: Serendipity or karma? [See comment]. Medical and Pediatric Oncology, 33(4), 409–410.
3. Pui, C. H., & Evans, W. E. (2006). Treatment of acute lymphoblastic leukemia. The New England Journal of Medicine, 354(2), 166–178.
4. Langebrake, C., Reinhardt, D., & Ritter, J. (2002). Minimising the long-term adverse effects of childhood leukaemia therapy. Drug Safety, 25(15), 1057–1077.
5. Ness, K. K., & Gurney, J. G. (2007). Adverse late effects of childhood cancer and its treatment on health and performance. Annual Review of Public Health, 28, 279–302.